Coronavirus Outbreak: Goa-based drug maker GAPL eyes to get licence to produce hydroxychloroquine sulfate

GAPL is a subsidiary of HLL Lifecare Limited under the administrative control of Union ministry of health and family welfare. The company has a manufacturing facility at Tuem in North Goa.

Press Trust of India April 10, 2020 16:06:32 IST
Coronavirus Outbreak: Goa-based drug maker GAPL eyes to get licence to produce hydroxychloroquine sulfate

Panaji: Goa Antibiotics Private Ltd (GAPL), a central public sector undertaking, has begun the process of procuring a licence to produce hydroxychloroquine sulfate, which has been approved by the US Food and Drug Administration (FDA) for treatment of COVID-19 .

 <span class=Coronavirus Outbreak Goabased drug maker GAPL eyes to get licence to produce hydroxychloroquine sulfate" width="380" height="285" />

Representational image. Reuters.

GAPL is a subsidiary of HLL Lifecare Limited under the administrative control of Union ministry of health and family welfare. The company has a manufacturing facility at Tuem in North Goa.

"The company has a licence to produce chloroquine sulfate (not hydroxychloroquine sulfate), but we have not produced it for the last 15 year. However, we have now decided to get licence for hydroxychloroquine sulfate considering the current demand," GAPL chief executive officer Reju Skaria said on Friday.

He said that the company has been producing various pharmaceutical products depending upon the demand.

"We have the capacity to produce two crore tablets per month. We can utilise this capacity to produce any pharmaceutical product, for which we have a licence," he said.

Skaria stated that there are difficulties in availability and transporting the Active Pharmaceutical Ingredient (API) required for the formations due to current lockdown.

Updated Date:

also read

Tamil Nadu lockdown extended till 19 July with more relaxations; check what's allowed & what's not
India

Tamil Nadu lockdown extended till 19 July with more relaxations; check what's allowed & what's not

The state authorities have now allowed restaurants, tea shops, bakeries, roadside shops and snack shops to operate with 50 percent capacity till 9 pm

COVID-19 vaccine production increasing, India may be first country to have DNA-based jab, Mansukh Mandaviya tells RS
India

COVID-19 vaccine production increasing, India may be first country to have DNA-based jab, Mansukh Mandaviya tells RS

Replying to a short discussion on COVID-19 management in Rajya Sabha, the minister said technology transfer to several companies has started and they will begin production in the coming days